HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kedar, E. Articles by Fahey, J. L. Search for Related Content PubMed Articles by Kedar, E. Articles by Fahey, J. L.

Comparative Studies of Immunoglobulin Receptors and Antibody-Dependent Cell Cytotoxicity (ADCC) in Rat Lymphoid Organs¹

From the Department of Microbiology and Immunology, University of California School of Medicine, Los Angeles, California 90024

Abstract

The capability of rat lymphoid cells to destroy antibody-coated target cells (antibody-dependent cell cytotoxicity, ADCC) and to form rosettes with immunoglobulin-coated erythrocytes (EA) was compared. Because both processes require binding of a lymphoid cell to antibody associated with cellular antigen, we undertook to determine if both assays detect the same cell population. Peripheral blood lymphocytes, spleen and lymph node cells had both activities, but there was no correlation between the number of rosettes and the ADCC activity. Blood lymphocytes had the highest cytotoxic potential, while spleen cells produced the highest percentage of rosettes. Bone marrow cells were devoid of cytotoxic activity though many of the cells were able to form rosettes. Thymus cells were neither cytotoxic nor able to form rosettes. Following treatment of spleen cells with 1) anti-rat Ig serum, 2) high concentrations (1 mg/ml) of trypsin and Pronase (but not papain), or phospholipase-C, the number of rosettes was strongly diminished, whereas the cytotoxic activity was unimpaired. The ADCC activity was not altered after removal of 60% of the rosetteforming cells by nylon column, but was greatly reduced when 85% of the rosette-forming cells were removed by anti-SRBC serum.

These observations indicate that: 1) there is no correlation between the percentage of EA rosette-forming cells and the ADCC activity in various lymphoid tissues, 2) these activities were not equally susceptible to enzymes' action, 3) the cytotoxic activity is mediated by a subpopulation of the EA rosette-forming cells, and 4) probably fewer immunoglobulin receptor sites per unit surface membrane are required for ADCC cytotoxicity than for rosette formation.

Footnotes

¹ This investigation was supported by Grant CA 12800 from the National Cancer Institute, National Institute of Health, Bethesda, Maryland.

² Recipient of a traveling grant from the Fulbright-Hays Foundation.